These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7971715)

  • 1. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers.
    Okada H; Doken Y; Ogawa Y; Toguchi H
    Pharm Res; 1994 Aug; 11(8):1143-7. PubMed ID: 7971715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
    Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
    J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of depot leuprorelin.
    Periti P; Mazzei T; Mini E
    Clin Pharmacokinet; 2002; 41(7):485-504. PubMed ID: 12083977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation study of leuprorelin acetate to improve clinical performance.
    Toguchi H
    Clin Ther; 1992; 14 Suppl A():121-30. PubMed ID: 1606592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent suppression of the pituitary-gonadal system in female rats by three-month depot injectable microspheres of leuprorelin acetate.
    Okada H; Doken Y; Ogawa Y
    J Pharm Sci; 1996 Oct; 85(10):1044-8. PubMed ID: 8897268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres.
    Choi SH; Park TG
    Int J Pharm; 2000 Aug; 203(1-2):193-202. PubMed ID: 10967441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A biodegradable polymeric system for peptide-protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process.
    Alcalá-Alcalá S; Urbán-Morlán Z; Aguilar-Rosas I; Quintanar-Guerrero D
    Int J Nanomedicine; 2013; 8():2141-51. PubMed ID: 23788833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Design and development of controlled release of drugs from injectable microcapsules].
    Takada S; Ogawa Y
    Nihon Rinsho; 1998 Mar; 56(3):675-9. PubMed ID: 9549355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
    Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
    Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide.
    Zhou J; Walker J; Ackermann R; Olsen K; Hong JKY; Wang Y; Schwendeman SP
    Mol Pharm; 2020 May; 17(5):1502-1515. PubMed ID: 32074448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres.
    Takada S; Kurokawa T; Miyazaki K; Iwasa S; Ogawa Y
    Pharm Res; 1997 Sep; 14(9):1146-50. PubMed ID: 9327440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.
    Wang J; Wang BM; Schwendeman SP
    Biomaterials; 2004 May; 25(10):1919-27. PubMed ID: 14738856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters.
    Lin SY; Chen KS; Teng HH; Li MJ
    J Microencapsul; 2000; 17(5):577-86. PubMed ID: 11038117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres.
    Ravivarapu HB; Burton K; DeLuca PP
    Eur J Pharm Biopharm; 2000 Sep; 50(2):263-70. PubMed ID: 10962237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres.
    Doty AC; Hirota K; Olsen KF; Sakamoto N; Ackermann R; Feng MR; Wang Y; Choi S; Qu W; Schwendeman A; Schwendeman SP
    Biomaterials; 2016 Dec; 109():88-96. PubMed ID: 27693924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method.
    Yamakawa I; Tsushima Y; Machida R; Watanabe S
    J Pharm Sci; 1992 Aug; 81(8):808-11. PubMed ID: 1403728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate.
    Okada H
    Adv Drug Deliv Rev; 1997 Oct; 28(1):43-70. PubMed ID: 10837564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Once-a-month injectable microcapsules of leuprorelin acetate].
    Toguchi H; Ogawa Y; Okada H; Yamamoto M
    Yakugaku Zasshi; 1991 Aug; 111(8):397-409. PubMed ID: 1795229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray-drying.
    Shi NQ; Zhou J; Walker J; Li L; Hong JKY; Olsen KF; Tang J; Ackermann R; Wang Y; Qin B; Schwendeman A; Schwendeman SP
    J Control Release; 2020 May; 321():756-772. PubMed ID: 31935481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended release peptide delivery systems through the use of PLGA microsphere combinations.
    Burton KW; Shameem M; Thanoo BC; DeLuca PP
    J Biomater Sci Polym Ed; 2000; 11(7):715-29. PubMed ID: 11011769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.